News

Recent Articles How Inaccurate Provider Data from Payers Impacts Access to Care Economic Wellness for Seniors Worsened from 2020 to 2022 Concerns about mental health are higher than during COVID ...
In 2022, health benefits spending will return to normal, prepandemic levels in 2022 by increasing by an average of 4.7 percent over 2021 healthcare costs, employers anticipated in Mercer’s ...
Humana added 50,000 individual Medicare Advantage beneficiaries and reported a net income of $741 million in the first quarter of 2024. The payer reported earnings per share (EPS) of $6.11 for ...
Provider Market Concentration Outweighs Payer Concentration August 06, 2018 by Thomas Beaton Healthcare provider systems tend to be bigger, more consolidated, and have more market share than ...
2024: Jan Feb Mar Apr May Jun CMS chops short-term, limited duration plan length to 4 months Medicare spending on GLP-1 drugs reached $5.7 billion in 2022 CMS final rule aims to simplify Medicaid ...
May 21, 2018 - Minnesota Governor Mark Dayton has signed a bill into law that allows patients and providers to execute overrides on payer step therapy programs for prescription drug treatments in ...
April 27, 2017 - A new report by the Commonwealth Fund found that Medicaid provides equal or better quality health coverage to private health insurance plans. The Commonwealth Fund’s 2016 ...
More than a third of individuals with continuous coverage switched health insurance plans during the 12 months before or after giving birth, a study published in JAMA Network Open found. Switching ...
BCBSA Settles Anti-Trust Litigation for $2.7B, Anthem Pays 22% November 05, 2020 by Kelsey Waddill Blue Cross Blue Shield Association (BCBSA) has nearly concluded an eight-year-long anti-trust ...
Trial Date Set for Aetna-Humana Health Insurance Merger August 12, 2016 by Vera Gruessner Health insurance companies and private physician practices or hospitals have often been on opposite sides ...
Private Payers Deny Hepatitis C Drug Coverage to 52% of Members June 13, 2018 by Thomas Beaton Private payers denied Hepatitis C drug coverage to 52.4 percent of commercially insured beneficiaries ...